Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Imagion Biosystems Ltd. ( (AU:IBX) ) just unveiled an announcement.
Imagion Biosystems Limited has applied to the ASX for quotation of 1.4 million new ordinary fully paid shares, to be traded under its existing ticker symbol IBX. The new securities, issued on 29 December 2025 following the exercise or conversion of existing options or other convertible securities, modestly increase the company’s listed share capital and provide additional liquidity for shareholders, though the announcement does not disclose any broader strategic or operational changes tied to this issuance.
The most recent analyst rating on (AU:IBX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Imagion Biosystems Ltd. stock, see the AU:IBX Stock Forecast page.
More about Imagion Biosystems Ltd.
Average Trading Volume: 3,879,403
Technical Sentiment Signal: Hold
Current Market Cap: A$12.64M
Learn more about IBX stock on TipRanks’ Stock Analysis page.